Back to Investors
GC

Ganexa Capital

Venture Capital

Portfolio

1

companies


Portfolio companies

Abtrace

Abtrace

Abtrace uses machine learning and artificial intelligence to transform the detection and treatment of chronic health conditions.


Recent investments

Seed
£2.1M

The funding round was led by Faber with participation from Ganexa Capital and Innovate UK.

"As it stands, the management of long-term health conditions is an inefficient process for patients and their GP practice. It involves multiple appointments, duplication of tests, and tons of admin. It doesn’t deliver the best for patients and also wastes valuable NHS time and resources. Abtrace is working at the interface of AI and healthcare to transform this."
— Umar Naeem Ahmad, CEO